Nanogen Subsidiary SynX Signs on Five European Distributors
Nanogen’s subsidiary SynX has signed on five European distributors for its point-of-care diagnostics products, Nanogen said this week.
The new distributors, which Nanogen did not name, expand SynX’s coverage to 28 European countries.
They will distribute and market SynX’s point-of-care tests and research products for congestive heart failure and myocardial infarction.
SynX said its CHF diagnostic test is expected to launch this year.